Results 41 to 50 of about 4,998,742 (298)

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Negative result measurements in mesoscopic systems

, 2003
We investigate measurement of electron transport in quantum dot systems by using single-electron transistor as a noninvasive detector. It is demonstrated that such a detector can operate in the ``negative-result measurement'' regime.
Gurvitz, S. A.
core   +2 more sources

Flux Qubit Readout in the Persistent Current Basis at arbitrary Bias Points

, 2020
Common flux qubit readout schemes are qubit dominated, meaning they measure in the energy eigenbasis of the qubit. For various applications meausrements in a basis different from the energy eigenbasis are required. Here we present an indirect measurement
Lupascu, Adrian, Schöndorf, Marius, Wilhelm, Frank K.   +2 more
core   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine, Ofélie Trudeau‐Ferrin, Caroline Laverdière, Patrick Hamel, Rosanne Superstein, Bénédicte Koukoui, Carole Provost, Paul C. Nathan, Vijay Ramaswamy, Furqan Shaikh, Brenda Gallie, Ashwin Mallipatna, Stephanie Kletke, Helen Dimaras, Hallie Coltin   +14 more
wiley   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source

Cholesterol measurement and current guidelines [PDF]

Vnitřní lékařství, 2022
The concentration of total cholesterol has so far been part of the SCORE tables for estimating the risk of cardiovascular events; in the new SCORE2 tables, it has already been replaced by non-HDL-cholesterol. Total cholesterol continues to serve as a guide for the presence of dyslipoproteinemia and is necessary for the calculation of LDL-cholesterol ...
openaire   +2 more sources

Outcome Measurement in Nonprofit Organizations: Current Practices and Recommendations [PDF]

, 2001
This report provides a view of the state of outcome measurement as implemented in a number of private nonprofit service organizations engaged in outcome measurement.
Elaine Morley, Elisa Vinson, Harry P. Hatry   +2 more
core  

Dynamics of a mesoscopic qubit under continuous quantum measurement [PDF]

, 2001
We present the conditional quantum dynamics of an electron tunneling between two quantum dots subject to a measurement using a low transparency point contact or tunnel junction.
A. Imamoglu, A. N. Korotkov, A. N. Korotkov, A. N. Korotkov, A. N. Korotkov, A. Shnirman, A. Shnirman, B. E. Kane, C. H. Crouch, C. Presilla, C. W. Gardiner, D. J. Wineland, D. Loss, D. P. DiVincenzo, D. V. Averin, D. W. Berry, F. R. Waugh, G. C. Hegerfeldt, G. Hackenbroich, G. W. Gardiner, Gerard J. Milburn, H. J. Carmichael, H. M. Wiseman, H. M. Wiseman, H. M. Wiseman, H.-S. Goan, Hsi-Sheng Goan, I. L. Aleiner, J. Dalibard, L. Stodolsky, M. B. Mensky, M. B. Plenio, M. Büttiker, M. J. Gagen, N. Gisin, N. Gisin, N. Gisin, N. H. Bonadeo, S. A. Gurvitz, T. Fujisawa, T. H. Oosterkamp, T. Tanamoto, V. Bouchiat, V. Privman, Y. Levinson, Y. Makhlin, Y. Makhlin, Y. Nakamura   +47 more
core   +2 more sources

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson, Ingrid Winship, Gary Hammerschlag, Laura Scardamaglia   +3 more
wiley   +1 more source

Evaluating the Precision of the DC Decay Test Method for Characterizing Wound-Field Synchronous Machines in Power Plants

IEEE Open Access Journal of Power and Energy, 2023
The sudden short-circuit test is the gold standard for determining the equivalent diagram of wound-field synchronous machines (WFSMs). Only a single measurement is needed while the machine is in saturated mode.
Frederic Maurer, Thomas Oyvang, Jonas Kristiansen Noland   +2 more
doaj   +1 more source